Literature DB >> 28597003

Endothelin: Ominous Player in Breast Cancer.

Anuradha Ratna1, Salil K Das1.   

Abstract

Entities:  

Year:  2015        PMID： 28597003      PMCID： PMC5460525     

Source DB:  PubMed          Journal:  J Cancer Clin Trials


× No keyword cloud information.
  18 in total

Review 1.  New therapeutics that antagonize endothelin: promises and frustrations.

Authors:  Giuseppe Remuzzi; Norberto Perico; Ariela Benigni
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

2.  Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.

Authors:  L Rosanò; M Varmi; D Salani; V Di Castro; F Spinella; P G Natali; A Bagnato
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 3.  Combining immunotherapy and targeted therapies in cancer treatment.

Authors:  Matthew Vanneman; Glenn Dranoff
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

Review 4.  Endothelins in breast tumour cell invasion.

Authors:  Matthew J Grimshaw
Journal:  Cancer Lett       Date:  2005-05-26       Impact factor: 8.679

Review 5.  Endothelin 1 in cancer: biological implications and therapeutic opportunities.

Authors:  Laura Rosanò; Francesca Spinella; Anna Bagnato
Journal:  Nat Rev Cancer       Date:  2013-07-25       Impact factor: 60.716

6.  Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma.

Authors:  K Alanen; D X Deng; S Chakrabarti
Journal:  Histopathology       Date:  2000-02       Impact factor: 5.087

7.  Role of endothelin-1 in neovascularization of ovarian carcinoma.

Authors:  D Salani; V Di Castro; M R Nicotra; L Rosanò; R Tecce; A Venuti; P G Natali; A Bagnato
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

8.  Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.

Authors:  A Bagnato; D Salani; V Di Castro; J R Wu-Wong; R Tecce; M R Nicotra; A Venuti; P G Natali
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

9.  A role for endothelin-2 and its receptors in breast tumor cell invasion.

Authors:  Matthew J Grimshaw; Thorsten Hagemann; Ayse Ayhan; Cheryl E Gillett; Claudia Binder; Frances R Balkwill
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

Review 10.  Endothelin-1: a multifunctional molecule in cancer.

Authors:  K Grant; M Loizidou; I Taylor
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640
View more
  4 in total

1.  Decitabine attenuates nociceptive behavior in a murine model of bone cancer pain.

Authors:  Camilla Kristine Appel; Nicole Newell Scheff; Chi Tonglien Viet; Brian Lee Schmidt; Anne-Marie Heegaard
Journal:  Pain       Date:  2019-03       Impact factor: 7.926

2.  A disintegrin and metalloproteinase domain 17-epidermal growth factor receptor signaling contributes to oral cancer pain.

Authors:  Nicole N Scheff; Yi Ye; Zachary R Conley; Jen Wui Quan; Yat Vong Ronald Lam; Richard Klares; Kamalpreet Singh; Brian L Schmidt; Bradley E Aouizerat
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

Review 3.  Synergy Between Low Dose Metronomic Chemotherapy and the pH-centered Approach Against Cancer.

Authors:  Tomas Koltai; Rosa A Cardone; Stephan J Reshkin
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

4.  Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling.

Authors:  Zaid H Maayah; Shingo Takahara; Abrar S Alam; Mourad Ferdaoussi; Gopinath Sutendra; Ayman O S El-Kadi; John R Mackey; Edith Pituskin; D Ian Paterson; Jason R B Dyck
Journal:  BMC Cancer       Date:  2020-08-12       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.